| 250 | 14 | 82 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探讨通腑降浊汤在热扰心神型肝性脑病患者治疗中的应用价值,观察其对患者炎性指标、肠黏膜屏障功能的影响,旨在为本病提供有效的治疗手段。方法:将2018年7月至2019年7月因肝性脑病于我院就诊且中医证型属于热扰心神型的76例患者纳入研究,用随机数字表法分组。所有患者均常规采用护肝降酶治疗,在此基础上对照组38例口服乳果糖,观察组38例联合通腑降浊汤灌肠治疗,治疗1周后比较临床疗效及实验室检查指标。结果:治疗后观察组血清内毒素(LPS)、血氨水平低于对照组,差异具有统计学意义(P<0.05);治疗后观察组血清肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平低于对照组,凝血酶原活动度(PTA)水平高于对照组,差异具有统计学意义(P<0.05);治疗后观察组血清总胆红素(TBIL)、丙氨酸转氨酶(ALT)水平低于对照组,差异具有统计学意义(P<0.05);治疗后观察组血清二胺氧化酶、D-乳酸等肠黏膜功能屏障指标水平低于对照组(P<0.05);治疗后观察组烦躁不安、乏力、嗜睡等症状积分水平低于对照组(P<0.05);观察组总有效率89.47%(34/38),高于对照组的68.42%(26/38),差异具有统计学意义(P<0.05)。结论:对于热扰心神型肝性脑病患者,通腑降浊汤灌肠治疗具有重要意义,可有效减轻炎症反应,改善肠黏膜屏障功能,改善凝血功能,促进病情好转。
Abstract:Objective:To explore the application value of Tongfu Jiangzhuo Decoction (通腑降浊汤 ) in the treatment hepatic encephalopathy(heat disturbing heart mind type),and to observe its effect on inflammatory indexes and intestinal mucosal barrier function,in order to provide an effective treatment for this disease.Methods:A total of 76 patients with liver encephalopathy of heat disturbing heart mind type treated in our hospital from July 2018 to July 2019 were included in the study and divided into different groups with a random number table. All patients were routinely treated with treatment for liver-protecting and enzymereducing. Besides this,38 patients in the control group received oral lactulose,and 38 patients in the observation group were treated with enema using traditional Chinese medicine Tongfu Jiangzhuo Decoction. The clinical efficacy was compared 1 week after the treatment. Results:Plasma lipopolysaccharide(LPS) and blood ammonia levels in the observation group after treatment were lower than those in the control group,and the differences were statistically significant(P<0.05);in the observation group after the treatment tumor necrosis factor(TNF)-α and interleukin(IL)-6 levels were lower than those in the control group,and prothrombin activity(PTA) levels were higher than those in the control group,with statistical differences(P <0.05);plasma total bilirubin(TBIL) and alanine aminotransferase(ALT) levels in the observation group after treatment were lower than those in the control group,and the differences were statistically significant(P<0.05);after the treatment,in the observation group plasma diamine oxidase,D-lactic acid were lower than those in the control group(P<0.05);after the treatment,the scores of irritability,fatigue,and somnolence in the observation group were lower than those in the control group(P<0.05);the total effective rate in the observation group was 89.47%(34/38),higher than 68.42%(26/38)in the control group,and the difference was statistically significant(P<0.05). Conclusions:For patients with hepatic encephalopathy( heat disturbing heart mind type), it is of great significance to combine Tongfu Jiangzhuo Decoction enema,for it can effectively reduce the inflammatory response,improve the intestinal mucosal barrier function,improve the coagulation function,and improve the condition.
[1]张纵,王晓花.肝性脑病诊断及治疗进展[J].山东大学学报(医学版),2018,56(2):1-8.
[2]刘琼,蔡克银.中医药治疗肝性脑病的研究进展[J].华南国防医学杂志,2018,32(2):142-143,145.
[3]张文凤.人工肝血浆置换联合分子吸附系统对重症肝炎肝硬化患者血清内毒素、细胞因子清除和肝功能的影响[J].标记免疫分析与临床,2018,25(6):863-866,917.
[4]郭梅,李雪梅.双歧三联活菌对肝硬化患者肠粘膜屏障功能及细胞免疫功能的影响[J].现代医院,2016,16(9):1275-1276.
[5]徐小元,丁惠国,李文刚,等.肝硬化肝性脑病诊疗指南[J].西南医科大学学报,2018,41(6):477-490.
[6]郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:162-167.
[7]中医病证诊断疗效标准编审委员会.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:86.
[8]张丽洁,周英霞,邢卉春,等.乙型肝炎肝硬化并发轻微肝性脑病的调查分析[J].临床肝胆病杂志,2018,34(4):770-774.
[9]汪艳.高氨血症在肝性脑病发生中的地位[J].肝脏,2018,23(8):660-661.
[10]黄翠,尤丽英.肝性脑病发病机制研究进展[J].云南医药,2018,39(5):453-455.
[11]王秦玉,鲁峰刚.乳果糖抗病毒对轻微肝性脑病血氨肝功能及Child-Pugh评分研究[J].山西医药杂志,2019,48(17):2123-2125.
[12]刘丹,万十千,朱清静.中药保留灌肠对慢性重型肝炎并肝性脑病患者血氨及细胞因子的影响[J].中西医结合肝病杂志,2018,28(2):85-87.
[13]张凤,徐旭娟,沈美云.肝性脑病食醋灌肠导致肠黏膜屏障损伤及改进方法[J].天津医药,2013,41(9):901-903,950.
[14]陈渠发,张锡迎,张宝庭,等.双歧杆菌三联活菌胶囊联合抗菌治疗对肝硬化自发性细菌性腹膜炎患者肠黏膜屏障功能的影响以及临床疗效分析[J].中国中西医结合消化杂志,2016,24(12):952-954.
[15]王荣,陈爱君.幽门螺杆菌感染对肝性脑病患者血清二胺氧化酶、内毒素水平的影响[J].中国实用医药,2016,11(31):23-25.
[16]李新荣,饶惠平,刘军.益生菌对肝硬化患者血清二胺氧化酶及内毒素水平的影响[J].海南医学,2018,29(10):1355-1358.
[17]王德力,舒生虎.抗纤软肝汤”对肝性脑病患者临床疗效及肠黏膜屏障功能的影响[J].江苏中医药,2019,51(7):30-33.
[18]谢能文,炉军,何金秋,等. HBV-ACLF肝性脑病患者IL-6、IL-10、TNF-α水平表达及意义[J].重庆医学,2017,46(9):1268-1271.
[19]闫建汶.醒脑静注射液联合还原型谷胱甘肽对肝性脑病病人IL-6和IL-18表达的影响[J].中西医结合心脑血管病杂志,2018,16(6):827-829.
[20]崔厚松.针刺十三鬼穴对肝性脑病患者血氨、内毒素、肿瘤坏死因子α的影响[J].北京中医药,2016,35(2):2016,35(2):167-169.
[21]杜丽娟,占煜,吴至久,等.大黄对便秘大鼠肠动力及结肠水通道蛋白3表达的调节作用[J].中华中医药学刊,2017,35(4):873.
[22]李冀,李想,高彦宇,等.中药石菖蒲研究进展[J].辽宁中医药大学学报,2019,21(10):13-17.
[23]翟蒙恩,张彬,李凯峰,等.厚朴酚对小鼠脓毒症心肌损伤的保护作用[J].西北大学学报(自然科学版),2018,48(6):787-792.
[24]王佳慧,李婧,李卫民.生地黄清热凉血功效量效关系的实验研究[J].中医临床研究,2019,11(15):140-141,144.
[25]王军,张流,熊华刚,等.醒脑静联合纳洛酮治疗肝性脑病患者认知和血清炎症因子水平变化[J].实用肝脏病杂志,2018,21(3):471-472.
[26]李文文,孟繁洁,靳英辉,等.西医常规治疗基础上中药保留灌肠治疗肝性脑病疗效的Meta分析[J].华西医学,2015,30(4):662-668.
基本信息:
DOI:10.16295/j.cnki.0257-358x.2021.06.007
中图分类号:R575.3
引用信息:
[1]边倩,解新科,寇小妮,等.通腑降浊汤联合乳果糖治疗热扰心神型肝性脑病临床观察[J],2021,40(06):577-582.DOI:10.16295/j.cnki.0257-358x.2021.06.007.
基金信息:
陕西中医药大学学科创新团队建设项目(编号:2019-YL05);; 第六批陕西省省级师承培训项目(批文号:陕中医药发[2018]35号);; 陕西省中医管理局中医药科研课题(编号:15-LC014)